Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 2,900 shares at $4.65 ($14K) on 2009-06-22, disclosed to the SEC on 2009-06-23.
Scheduled sale ($14k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.74 | 1,700 | $8K | 59.1% |
| 2 | $4.65 | 1,200 | $6K | 40.9% |
| Total | $4.70 avg | 2,900 | $14K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |